Related Experiment Videos
mdm-2 oncogene expression in non-Hodgkin's lymphomas
1Department of Medical Oncology, Cedars Sinai Medical Center, Los Angeles, California, USA.
Abstract:
The mdm-2 protein is a 90-kD protein that forms a complex with the p53 protein, enabling cells from some human neoplasms to overcome the growth-suppressing activity of p53. Most non-Hodgkin's lymphomas lack p53 mutations, and the mechanism of inactivation of tumor suppressive function remains obscure. To assess the role of mdm-2 in lymphomagenesis, 22 cases were evaluated for mdm-2 gene amplification or rearrangement in Southern blots. Localization of the mdm-2 protein was performed on cryostat sections and compared with expression of the p53 gene product. No case exhibited mdm-2 gene amplification or rearrangement, but overexpression of nuclear mdm-2 gene protein product was found in three of six diffuse large cell (B-cell immunoblastic) lymphomas (30-70% of the tumor cells stained). The mdm-2 protein was absent from low- and intermediate-grade lymphomas with the exception of a few cells (5% or less) in four cases. The mdm-2-positive cases stained negative for p53. Southern blot analysis showed that samples overexpressing mdm-2 did not have amplification or rearrangement of the gene. In summary, amplification of the mdm-2 gene does not appear to play a prominent role in the pathogenesis of non-Hodgkin's lymphomas, although overexpression of the protein gene product occurs, particularly in high-grade neoplasms.
Insights
Amplification of the mdm-2 gene is not a key factor in non-Hodgkin
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The mdm-2 protein interacts with p53, potentially overriding its tumor-suppressive functions in human neoplasms.
- Most non-Hodgkin's lymphomas lack p53 mutations, leaving the mechanism of tumor suppressor inactivation unclear.
- Understanding mdm-2's role is crucial for elucidating lymphomagenesis pathways.
Purpose of the Study:
- To investigate the role of mdm-2 gene amplification and rearrangement in the pathogenesis of non-Hodgkin's lymphomas.
- To assess mdm-2 protein expression and localization in relation to p53 in lymphoma cases.
Main Methods:
- Southern blot analysis was used to evaluate mdm-2 gene amplification and rearrangement in 22 lymphoma cases.
- Immunohistochemistry on cryostat sections was performed to determine mdm-2 protein localization and expression.
- p53 gene product expression was assessed and compared with mdm-2 findings.
Main Results:
- No instances of mdm-2 gene amplification or rearrangement were detected in any of the evaluated cases.
- Overexpression of the nuclear mdm-2 protein product was observed in 3 of 6 diffuse large cell lymphomas.
- mdm-2 protein was largely absent in low- and intermediate-grade lymphomas, and mdm-2 positive cases were negative for p53.
Conclusions:
- mdm-2 gene amplification does not appear to be a significant factor in the development of non-Hodgkin's lymphomas.
- Overexpression of the mdm-2 protein product occurs in certain high-grade non-Hodgkin's lymphomas, suggesting a potential role.
- The findings highlight a possible mechanism of p53 inactivation independent of gene mutation in these lymphomas.